infect
extern
auditori
canal
otiti
externa
similar
infect
skin
soft
tissu
elsewher
uniqu
problem
occur
canal
narrow
tortuou
fluid
foreign
object
enter
trap
caus
irrit
macer
superfici
tissu
pain
itch
result
may
sever
limit
space
expans
inflam
tissu
infect
extern
canal
may
subdivid
four
categori
acut
local
otiti
externa
acut
diffus
otiti
externa
chronic
otiti
externa
malign
otiti
externa
review
senturia
cowork
hirsch
rubin
yu
provid
complet
inform
extern
auditori
canal
approxim
cm
long
concha
auricl
tympan
membran
later
half
canal
cartilagin
medial
half
tunnel
tempor
otiti
externa
infect
inflamm
extern
auditori
canal
acut
otiti
media
aom
acut
ill
mark
presenc
fluid
middl
ear
inflamm
mucosa
line
middl
ear
space
fluid
may
persist
middl
ear
week
month
appropri
treat
aom
term
otiti
media
effus
mastoid
infect
inflamm
mastoid
air
cell
usual
result
episod
sever
aom
acut
diffus
otiti
externa
swimmer
ear
occur
hot
humid
weather
invas
malign
otiti
externa
occur
diabet
immunocompromis
debilit
patient
children
prone
place
foreign
object
extern
ear
canal
may
caus
macer
infect
skin
line
extern
canal
otiti
media
occur
age
peak
age
group
children
first
year
life
children
risk
sever
recurr
otiti
media
frequent
male
genet
predisposit
ear
infect
may
largegroup
daycar
expos
frequent
respiratori
virus
bacteri
pathogen
epidemiolog
mastoid
parallel
otiti
media
microbi
microbiota
extern
ear
canal
respons
otiti
externa
similar
skin
elsewher
includ
staphylococc
speci
anaerob
bacteria
pseudomona
aeruginosa
frequent
caus
swimmer
ear
malign
otiti
externa
microbiolog
mastoid
similar
aom
patient
persist
perfor
tympan
membran
may
invas
mastoid
organ
present
extern
ear
canal
includ
aureu
p
aeruginosa
acut
local
otiti
externa
may
occur
pustul
furuncl
visual
canal
swimmer
ear
identifi
edema
swell
erythema
canal
wall
malign
otiti
externa
associ
sever
pain
tender
tissu
around
pinna
mastoid
pu
may
present
canal
aom
acut
ill
fluid
middl
ear
bulg
decreas
mobil
inflamm
tympan
membran
sign
mastoid
includ
swell
red
tender
mastoid
bone
pinna
displac
downward
outward
purul
discharg
may
emerg
perfor
tympan
membran
swimmer
ear
may
manag
gentl
cleans
irrig
extern
canal
antibiot
solut
includ
fluoroquinolon
eardrop
effect
local
infect
system
antimicrobi
therapi
includ
activ
p
aeruginosa
necessari
manag
invas
extern
otiti
media
highdos
amoxicillin
prefer
drug
patient
aom
amoxicillin
fail
amoxicillinclavulan
parenter
ceftriaxon
prefer
children
aom
improv
without
use
antimicrobi
agent
placement
tympanostomi
tube
may
warrant
children
sever
recurr
episod
aom
antimicrobi
therapi
similar
aom
incis
drainag
may
necessari
abscess
form
mastoid
air
cell
patient
dissuad
place
foreign
object
includ
cottontip
applic
extern
canal
chemoprophylaxi
may
valu
prevent
episod
aom
children
sever
recurr
diseas
pneumococc
conjug
vaccin
effect
reduc
episod
aom
due
vaccin
serotyp
influenza
viru
vaccin
reduc
incid
aom
winter
respiratori
season
prevent
similar
aom
older
diabet
immunocompromis
debilit
patient
particular
risk
lifethreaten
diseas
may
result
spread
tempor
bone
sigmoid
sinu
jugular
bulb
base
skull
mening
brain
perman
facial
paralysi
frequent
cranial
nerv
may
also
affect
p
aeruginosa
almost
alway
caus
agent
see
chapter
extent
damag
soft
tissu
bone
may
identifi
monitor
use
comput
tomographi
magnet
reson
imag
diagnost
test
underli
diseas
institut
canal
cleans
devit
tissu
remov
eardrop
antipseudomon
antibiot
combin
steroid
instil
extern
auditori
canal
system
therapi
regimen
includ
activ
pseudomona
spp
use
week
combin
ceftazidim
cefepim
piperacillin
aminoglycosid
gentamicin
tobramycin
consid
oral
quinolon
activ
pseudomona
spp
ciprofloxacin
effect
therapi
earli
cours
invas
extern
otiti
aspergillu
speci
particularli
niger
may
grow
cerumen
desquam
keratinac
debri
extern
auditori
canal
sometim
form
visibl
greenish
blackish
fluffi
coloni
role
mold
acut
otiti
externa
usual
modest
although
sever
immunocompromis
patient
aspergillu
caus
necrot
otiti
externa
candida
albican
frequent
caus
extern
otiti
children
chronic
mucocutan
candidiasi
acut
otiti
media
aom
defin
acut
ill
mark
presenc
middl
ear
fluid
inflamm
mucosa
line
middl
ear
space
otiti
media
effus
ome
defin
presenc
middl
ear
fluid
without
acut
sign
ill
inflamm
middl
ear
mucosa
usual
follow
aom
may
also
occur
result
barotrauma
allergi
peak
incid
occur
first
year
life
diseas
less
common
schoolag
child
adolesc
adult
nevertheless
infect
middl
ear
may
caus
fever
signific
pain
impair
hear
age
group
addit
adult
suffer
sequela
otiti
media
childhood
hear
loss
cholesteatoma
adhes
otiti
media
chronic
perfor
tympan
membran
three
recent
factor
alter
incid
microbiolog
manag
otiti
media
introduct
conjug
pneumococc
vaccin
unit
state
vaccin
reduc
number
episod
vaccin
serotyp
pneumococc
aom
decreas
incid
sever
recurr
diseas
program
develop
center
diseas
control
prevent
cdc
advocaci
group
inform
health
care
worker
consum
appropri
use
antimicrobi
agent
avoid
use
drug
trivial
usual
viral
respiratori
tract
infect
decreas
select
multidrugresist
bacteria
public
manag
guidelin
american
academi
pediatr
aap
american
academi
famili
physician
aafp
present
criteria
manag
aom
without
antimicrobi
agent
interest
reader
refer
aapaafp
guidelin
manag
aom
ome
otiti
media
infant
children
blueston
klein
epidemiolog
year
age
two
third
children
one
episod
aom
one
third
three
episod
highest
incid
aom
occur
month
age
subsequ
incid
declin
age
except
limit
revers
downward
trend
year
age
time
school
entri
otiti
media
infrequ
adult
bacteriolog
therapi
similar
children
longitudin
studi
provid
inform
characterist
children
recurr
sever
episod
aom
bone
constrict
isthmu
present
junctur
osseou
cartilagin
portion
limit
entri
wax
foreign
bodi
area
near
tympan
membran
skin
canal
thicker
cartilagin
portion
includ
welldevelop
dermi
subcutan
layer
skin
line
osseou
portion
thinner
firmli
attach
periosteum
lack
subcutan
layer
hair
follicl
numer
outer
third
spars
inner
two
third
canal
cerumen
debri
epitheli
cell
accumul
canal
extrud
normal
cleans
mechan
occas
materi
may
becom
inspiss
obstruct
canal
microbi
flora
extern
canal
similar
flora
skin
elsewher
predomin
staphylococcu
epidermidi
staphylococcu
aureu
corynebacteria
lesser
extent
anaerob
bacteria
propionibacterium
acn
pathogen
respons
infect
middl
ear
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
uncommonli
found
cultur
extern
auditori
canal
tympan
membran
intact
epithelium
absorb
moistur
environ
desquam
denud
superfici
layer
epithelium
may
follow
warm
moist
environ
organ
canal
may
flourish
invad
macer
skin
inflamm
suppur
follow
invas
organ
includ
normal
skin
flora
gramneg
bacilli
particularli
pseudomona
aeruginosa
invas
otiti
media
necrot
infect
frequent
associ
p
aeruginosa
organ
gain
access
deeper
tissu
ear
canal
caus
local
vascul
thrombosi
necrosi
tissu
diabet
microangiopathi
skin
overli
tempor
bone
result
poor
local
perfus
milieu
invas
p
aeruginosa
acut
local
otiti
externa
may
occur
pustul
furuncl
associ
hair
follicl
extern
ear
canal
erythemat
edemat
may
fill
pu
flake
skin
debri
aureu
frequent
pathogen
erysipela
caus
group
streptococcu
may
involv
concha
canal
pain
may
sever
bluishr
hemorrhag
bulla
may
present
osseou
canal
wall
also
tympan
membran
adenopathi
lymphat
drainag
area
often
present
local
heat
system
antibiot
usual
cur
incis
drainag
may
necessari
reliev
sever
pain
acut
diffus
otiti
externa
swimmer
ear
occur
mainli
hot
humid
weather
ear
itch
becom
increasingli
pain
skin
canal
edemat
red
gramneg
bacilli
mainli
p
aeruginosa
may
play
signific
role
sever
hemorrhag
extern
otiti
caus
p
aeruginosa
associ
mobil
redwood
hot
tub
system
gentl
cleans
remov
debri
includ
irrig
warm
tap
water
reduc
symptom
altern
hyperton
salin
cleans
mixtur
alcohol
acet
acid
may
use
hydrophil
solut
burrow
solut
may
use
day
reduc
inflamm
cotton
wick
may
valu
enhanc
distribut
ototop
agent
canal
swollen
regimen
fluoroquinolon
otic
solut
ofloxacin
ciprofloxacindexamethason
otic
eardrop
neomycin
alon
polymyxin
combin
hydrocortison
effect
reduc
local
inflamm
infect
chronic
otiti
externa
caus
irrit
drainag
perfor
tympan
membran
underli
caus
chronic
suppur
otiti
media
itch
may
sever
manag
direct
treatment
middl
ear
disord
rare
caus
chronic
otiti
externa
includ
tuberculosi
syphili
yaw
leprosi
sarcoidosi
invas
malign
otiti
externa
sever
necrot
infect
spread
squamou
epithelium
ear
canal
adjac
area
soft
tissu
blood
vessel
cartilag
bone
see
chapter
sever
pain
tender
tissu
around
ear
mastoid
accompani
drainag
pu
canal
bacteriolog
otiti
media
document
appropri
cultur
middl
ear
effus
obtain
needl
aspir
mani
studi
bacteriolog
aom
perform
result
remark
consist
demonstr
import
pneumonia
h
influenza
age
group
recent
studi
sinc
introduct
pneumococc
conjug
vaccin
suggest
h
influenza
may
replac
pneumonia
frequent
isol
pathogen
aom
children
tabl
pneumonia
remain
import
bacteri
caus
otiti
media
region
world
rel
serotyp
respons
diseas
although
may
variat
serotyp
variou
region
world
common
serotyp
order
decreas
frequenc
introduc
contain
serotyp
replac
ad
serotyp
effect
reduc
incid
aom
caus
vaccin
serotyp
data
yet
avail
determin
ad
benefit
otiti
media
caus
h
influenza
associ
nontyp
strain
vast
major
patient
approxim
case
otiti
caus
h
influenza
type
b
frequent
sever
accompani
bacteremia
mening
type
b
rare
efficaci
conjug
polysaccharid
vaccin
nontyp
strain
h
influenza
signific
caus
otiti
media
patient
age
h
influenza
primari
pathogen
uniqu
conjunctivitisaom
syndrom
moraxella
catarrhali
isol
approxim
children
aom
usual
associ
mild
form
diseas
almost
strain
catarrhali
sensit
penicillin
today
strain
produc
resist
penicillin
g
ampicillin
amoxicillin
aureu
includ
methicillin
multidrugresist
strain
uncommon
caus
aom
may
associ
persist
otorrhea
follow
insert
tympanostomi
tube
preantibiot
era
aom
caus
group
streptococcu
ga
frequent
caus
sever
aom
frequent
complic
mastoid
often
associ
scarlet
fever
reason
unknown
aom
caus
ga
uncommon
recent
survey
israel
identifi
ga
respons
episod
aom
virolog
epidemiolog
studi
suggest
viral
infect
frequent
initi
event
develop
aom
respiratori
virus
isol
nasopharynx
children
aom
detect
approxim
middl
ear
fluid
children
aom
respiratori
syncyti
viru
influenza
viru
enterovirus
coronavirus
rhinovirus
common
virus
found
middl
ear
fluid
combin
viral
bacteri
infect
frequent
may
sever
bacteri
infect
alon
chonmaitre
cowork
vast
major
children
obviou
defect
respons
sever
recurr
otiti
media
small
number
anatom
chang
cleft
palat
cleft
uvula
submuc
cleft
alter
normal
physiolog
defens
patul
eustachian
tube
congenit
acquir
immunolog
defici
increas
incid
aom
occur
children
syndrom
children
acquir
immunodefici
syndrom
higher
agespecif
incid
otiti
media
begin
month
age
uninfect
children
children
initi
posit
human
immunodefici
viru
antibodi
serorevert
true
infecti
diseas
childhood
aom
occur
often
male
femal
correl
index
child
sever
recurr
aom
sibl
parent
identifi
like
genet
suscept
proinflammatori
cytokin
gene
polymorph
polymorph
immunorespons
gene
associ
recurr
aom
age
time
first
episod
aom
appear
among
power
predictor
recurr
middl
ear
infect
breastfeed
month
associ
decreas
risk
aom
first
year
life
race
ethnic
provid
addit
data
suggest
genet
basi
recurr
middl
ear
infect
nativ
american
alaskan
canadian
eskimo
aborigin
extraordinari
incid
sever
otiti
media
role
increas
exposur
infecti
agent
import
environment
pollut
identifi
studi
incid
infect
group
daycar
effect
passiv
smoke
children
introduct
infant
larg
daycar
group
increas
incid
respiratori
infect
includ
otiti
media
daycar
risk
infect
associ
number
children
facil
children
largegroup
daycar
almost
one
episod
respiratori
tract
infect
month
occur
first
year
life
aom
complic
one
third
one
half
respiratori
tract
infect
children
daycar
episod
aom
children
home
care
sever
diseas
measur
need
surgic
procedur
studi
pittsburgh
children
observ
birth
second
year
life
note
myringotomi
tympanostomi
tube
placement
perform
children
group
daycar
children
home
care
exposur
tobacco
smoke
document
measur
nicotin
metabolit
cotinin
saliva
urin
correl
increas
incid
new
episod
ome
durat
effus
kim
cowork
identifi
associ
invas
pneumococc
diseas
otiti
media
atmospher
condit
air
pollut
identifi
level
sulfur
dioxid
isol
respiratori
virus
middl
ear
part
continu
system
includ
nare
nasopharynx
eustachian
tube
medial
anteriorli
mastoid
air
cell
posteriorli
structur
line
respiratori
epithelium
contain
ciliat
cell
mucussecret
goblet
cell
cell
capabl
secret
local
immunoglobulin
anatom
physiolog
dysfunct
eustachian
tube
appear
play
critic
role
develop
otiti
media
eustachian
tube
least
three
physiolog
function
respect
middl
ear
protect
ear
nasopharyng
secret
drainag
nasopharynx
secret
produc
within
middl
ear
ventil
middl
ear
equilibr
air
pressur
extern
ear
canal
one
function
compromis
result
may
develop
fluid
infect
middl
ear
episod
aom
occur
follow
sequenc
congest
mucosa
upper
respiratori
tract
often
caus
respiratori
viral
infect
swell
mucosa
eustachian
tube
progress
obstruct
tube
narrowest
section
isthmu
secret
constantli
form
mucosa
middl
ear
accumul
behind
obstruct
bacteri
pathogen
present
aom
may
result
pathogenesi
fluid
persist
week
month
episod
adequ
treat
aom
persist
ome
remain
uncertain
recent
studi
suggest
bacteri
biofilm
middl
ear
mucosa
may
play
role
chronic
ome
ome
addit
profession
model
consum
model
innovia
medic
omaha
ne
avail
permit
home
monitor
develop
persist
middl
ear
fluid
fluid
persist
middl
ear
prolong
period
onset
aom
even
though
symptom
usual
resolv
within
day
initi
antimicrobi
therapi
children
otiti
media
fluid
middl
ear
week
onset
diseas
still
fluid
month
onset
still
fluid
month
first
sign
middl
ear
infect
patient
middl
ear
effus
suffer
hear
loss
variabl
sever
averag
patient
fluid
middl
ear
pureton
averag
loss
develop
speech
languag
cognit
skill
dynam
infanc
incid
aom
highest
concern
impedi
recept
interpret
auditori
stimuli
might
advers
effect
children
histori
recurr
episod
aom
score
lower
test
speech
languag
cognit
abil
diseasefre
peer
result
microbiolog
studi
middl
ear
effus
patient
aom
consist
choic
antimicrobi
agent
may
base
knowledg
bacteriolog
characterist
otiti
media
acquir
mani
investig
rather
result
cultur
site
throat
nasopharynx
see
tabl
patient
toxic
focal
infect
elsewher
cultur
sampl
blood
focal
infect
warrant
needl
aspir
middl
ear
effus
tympanocentesi
defin
microbiolog
characterist
infect
consid
select
patientsth
patient
critic
ill
onset
patient
respond
initi
antimicrobi
therapi
hour
toxic
patient
alter
host
defens
eg
immunolog
defect
includ
newborn
infant
prefer
antimicrobi
agent
patient
aom
must
activ
pneumonia
h
influenza
catarrhali
group
streptococci
aureu
infrequ
caus
aom
need
consid
initi
therapeut
decis
gramneg
enter
bacilli
methicillinresist
aureu
must
consid
otiti
media
occur
newborn
infant
patient
depress
immun
respons
patient
suppur
complic
chronic
otiti
media
antimicrobi
agent
achiev
concentr
middl
ear
fluid
expect
minim
inhibitori
concentr
like
pathogen
craig
and
examin
relationship
bacteriolog
cure
otiti
media
serum
middl
ear
fluid
concentr
variou
antimicrobi
agent
found
bacteriolog
cure
requir
presenc
serum
concentr
minim
inhibitori
concentr
least
dose
interv
antimicrobi
agent
approv
us
food
drug
administr
fda
aom
amoxicillin
remain
drug
choic
initi
treatment
record
clinic
success
accept
limit
side
effect
rel
low
cost
drug
ineffect
strain
h
influenza
catarrhali
current
incid
amoxicillinresist
h
influenza
catarrhali
high
enough
requir
chang
initi
therapi
recent
recommend
increas
dosag
amoxicillin
mgkgday
achiev
higher
concentr
middl
ear
fluid
reduc
number
children
amoxicillin
therapi
fail
resist
pneumococci
altern
amoxicillin
includ
amoxicillinclavulan
three
sulfacontain
trimethoprimcontain
prepar
erythromycin
plu
sulfisoxazol
trimethoprim
trimethoprimsulfamethoxazol
two
macrolid
azithromycin
clarithromycin
nine
oral
cephalosporin
cephalexin
cefaclor
cefixim
ceftibuten
cefprozil
cefpodoxim
cefuroxim
axetil
loracarbef
cefdinir
one
parenter
cephalosporin
ceftriaxon
two
topic
fluoroquinolon
ofloxacin
ciprofloxacindexamethason
otic
effect
children
tympanostomi
tube
suffer
acut
otorrhea
note
higher
proport
patient
viru
bacteria
middl
ear
fluid
fail
clear
bacteria
day
initi
therapi
compar
group
bacteria
alon
mycoplasma
pneumonia
respons
hemorrhag
bullou
myring
studi
nonimmun
volunt
inocul
organ
howev
middl
ear
fluid
larg
number
patient
studi
pneumonia
isol
one
case
although
mycoplasma
appear
play
signific
role
aom
patient
lower
respiratori
tract
diseas
caus
pneumonia
may
concomit
otiti
media
chlamydia
trachomati
associ
acut
respiratori
infect
infant
younger
month
caus
acut
infect
middl
ear
age
group
organ
isol
middl
ear
fluid
infant
acut
infect
uncommon
form
otiti
includ
diphtherit
otiti
tubercul
otiti
otogen
tetanu
otiti
caus
mycobacterium
chelona
otiti
caus
ascari
lumbricoid
wegen
granulomatosi
fungi
frequent
associ
extern
otiti
rare
caus
aom
candida
aspergillu
spp
isol
middl
ear
fluid
immunodefici
patient
develop
chronic
suppur
otiti
media
middl
ear
site
secretori
immun
system
similar
area
respiratori
tract
local
system
immun
respons
occur
patient
acut
chronic
ome
middl
ear
immunolog
activ
antigen
interact
immunocompet
cell
lamina
propria
produc
local
immun
respons
middl
ear
effus
result
acut
chronic
infect
contain
major
class
immunoglobulin
complement
cell
immun
complex
antigen
antibodi
variou
chemic
mediat
inflamm
role
substanc
cours
otiti
media
uncertain
immun
respons
variou
antigen
may
prevent
subsequ
infect
assist
clearanc
fluid
acut
episod
contribut
accumul
persist
fluid
middl
ear
caviti
becom
cultur
medium
next
infect
acut
otiti
media
defin
presenc
fluid
middl
ear
along
sign
symptom
acut
ill
inflamm
mucosa
middl
ear
identifi
erythema
tympan
membran
sign
symptom
may
specif
ear
pain
ear
drainag
hear
loss
nonspecif
fever
lethargi
irrit
vertigo
nystagmu
tinnitu
may
occur
red
tympan
membran
earli
sign
otiti
media
erythema
alon
diagnost
middl
ear
infect
may
caus
inflamm
mucosa
throughout
upper
respiratori
tract
howev
aom
may
present
intens
erythema
tympan
membran
otoscop
find
presenc
fluid
middl
ear
determin
use
pneumat
otoscopi
techniqu
permit
assess
mobil
tympan
membran
motion
tympan
membran
proport
pressur
appli
gentli
squeez
releas
rubber
bulb
attach
head
otoscop
normal
mobil
appar
posit
pressur
appli
tympan
membran
move
rapidli
inward
releas
bulb
result
neg
pressur
membran
move
outward
fluid
high
neg
pressur
middl
ear
dampen
mobil
tympan
membran
adjunct
techniqu
avail
confirm
result
otoscop
examin
assist
accuraci
diagnosi
tympanometri
use
electroacoust
imped
bridg
record
complianc
tympan
membran
middl
ear
pressur
techniqu
present
object
evid
statu
middl
ear
presenc
absenc
fluid
acoust
reflectometri
measur
sound
reflect
middl
ear
abl
distinguish
airor
fluidfil
space
spatial
gradient
analysi
correl
probabl
middl
ear
effus
children
antimicrobi
agent
placebo
document
efficaci
antimicrobi
agent
modifi
dosag
reduc
number
episod
acut
febril
ill
caus
otiti
media
howev
modifi
dosag
form
antimicrobi
agent
may
select
resist
strain
nasopharynx
chemoprophylaxi
consid
children
sever
recurr
infect
children
consid
prophylaxi
two
episod
aom
first
month
life
older
children
three
episod
month
four
episod
year
amoxicillin
mgkg
sulfisoxazol
mgkg
may
administ
daili
chemoprophylaxi
may
suppress
symptom
otiti
media
asymptomat
middl
ear
effus
may
persist
physician
choos
use
chemoprophylaxi
prevent
acut
recurr
diseas
must
examin
patient
approxim
interv
middl
ear
effus
concern
develop
multidrugresist
bacteria
patient
receiv
chemoprophylaxi
guidelin
aap
aafp
discourag
chemoprophylaxi
guidelin
suggest
prevent
placement
tympanostomi
tube
although
necessit
surgic
procedur
anesthesia
physician
must
discuss
parent
riskbenefit
ratio
antibiot
prophylaxi
versu
surgeri
prevent
sever
aom
polysaccharid
pneumococc
vaccin
evalu
prevent
recurr
aom
children
children
younger
year
age
unsatisfactori
respons
singledos
regimen
vaccin
limit
efficaci
prevent
aom
sevenval
conjug
pneumococc
polysaccharid
vaccin
use
diphtheria
toxin
mutant
crm
protein
carrier
prevnar
pfizer
vaccin
philadelphia
pa
approv
fda
februari
vaccin
combin
pneumococc
serotyp
demonstr
immunogen
children
young
month
age
antibodi
titer
protect
prevent
invas
diseas
achiev
dose
administ
month
wane
next
month
requir
booster
age
month
effect
prevent
vaccinetyp
invas
diseas
efficaci
children
immun
per
protocol
pneumonia
decreas
radiograph
identifi
diseas
result
modest
prevent
aom
vaccin
reduc
number
episod
aom
reduc
number
procedur
placement
ventil
tube
reflect
recurr
episod
requir
placement
tube
bacteriolog
efficaci
evalu
prevent
aom
finnish
infant
bacteriolog
diagnosi
base
aspir
middl
ear
fluid
patient
aom
complet
infant
threedos
schedul
tabl
similar
studi
northern
california
vaccin
reduc
incid
aom
reduct
number
episod
pneumococc
aom
reduct
episod
caus
vaccin
serotyp
diseas
concern
patient
fail
amoxicillin
therapi
prefer
regimen
includ
increas
dosag
amoxicillin
clavulan
mgkgday
two
dose
intramuscular
ceftriaxon
mgkg
day
day
children
sever
recurr
aom
use
tympanocentesi
identifi
bacteri
pathogen
suscept
pattern
may
necessari
choos
effect
drug
children
known
sever
allergi
antibiot
macrolid
erythromycin
plu
sulfisoxazol
azithromycin
clarithromycin
prefer
trimethoprimsulfamethoxazol
may
use
region
pneumococc
resist
combin
concern
children
aom
caus
bacteri
pathogen
improv
without
use
antimicrobi
agent
howi
ploussard
perform
dual
aspir
middl
ear
fluid
children
aom
day
apart
placebo
given
instead
antibacteri
drug
found
middl
ear
fluid
infect
initi
pneumococci
becam
steril
middl
ear
fluid
infect
initi
h
influenza
becam
steril
discrep
proport
infect
becom
steril
infect
two
bacteri
speci
indic
simpl
mechan
effect
drainag
infect
fluid
via
patent
eustachian
tube
perfor
tympan
membran
unlik
respons
microbiolog
effect
like
host
mechan
probabl
base
humor
cellular
immun
act
preferenti
rid
infect
ear
h
influenza
frequent
pneumonia
microbiolog
result
indic
mani
children
aom
caus
viral
pathogen
episod
bacteri
otiti
media
resolv
without
antibacteri
drug
prompt
european
physician
withhold
antibiot
therapi
children
ear
infect
option
observ
children
aom
rather
initi
antimicrobi
therapi
practic
extens
western
europ
aap
aafp
propos
similar
protocol
withhold
antimicrobi
therapi
children
older
year
age
whose
diagnosi
uncertain
sever
diseas
sever
diseas
defin
moder
sever
otalgia
fever
c
f
higher
appropri
antimicrobi
therapi
children
aom
significantli
improv
within
hour
improv
patient
reexamin
child
may
develop
new
focu
infect
receiv
inadequ
therapi
aom
may
pain
due
pressur
expand
abscess
tympan
membran
pain
present
analges
treatment
consid
acetaminophen
ibuprofen
effect
analgesia
mild
moder
pain
narcot
analgesia
codein
analogu
effect
sever
pain
care
consid
risk
respiratori
depress
alter
mental
statu
incis
drainag
middl
ear
abscess
mean
tympanostomi
myringotomi
usual
requir
otolaryngolog
support
provid
immedi
relief
nasal
oral
decongest
administ
alon
combin
antihistamin
use
extens
treatment
ome
use
drug
base
consider
reduc
congest
respiratori
mucosa
reliev
obstruct
eustachian
tube
result
inflamm
caus
respiratori
infect
result
clinic
trial
howev
indic
signific
evid
efficaci
prepar
use
alon
combin
relief
sign
diseas
decreas
time
spent
middl
ear
effus
prevent
acut
otiti
media
prevent
sever
recurr
episod
aom
includ
chemoprophylaxi
use
bacteri
viral
vaccin
surgeri
chemoprophylaxi
shown
valu
prevent
acut
ill
children
suffer
recurr
middl
ear
infect
varieti
studi
includ
variou
tube
also
valu
patient
difficulti
maintain
ambient
pressur
middl
ear
occur
barotrauma
airlin
personnel
liabil
placement
tube
includ
anesthesia
associ
procedur
persist
perfor
scar
tympan
membran
develop
cholesteatoma
otiti
media
caus
swim
ventil
tube
place
occur
infrequ
mastoid
portion
petrou
tempor
bone
lie
superior
middl
ear
caviti
mastoid
fill
system
interconnect
airfil
cell
mastoid
antrum
serv
open
canal
middl
ear
mastoid
air
cell
fig
thu
case
aom
fluid
fill
middl
ear
space
associ
degre
inflamm
mastoid
air
cell
incid
clinic
signific
mastoid
howev
low
sinc
introduct
antimicrobi
agent
nevertheless
acut
chronic
aom
still
occur
may
respons
signific
morbid
lifethreaten
diseas
birth
mastoid
consist
singl
cell
antrum
connect
middl
ear
small
channel
pneumat
mastoid
bone
take
place
soon
birth
extens
year
age
clinic
import
mastoid
relat
contigu
structur
includ
posterior
cranial
fossa
middl
cranial
fossa
sigmoid
later
sinus
canal
facial
nerv
semicircular
canal
petrou
tip
tempor
bone
mastoid
air
cell
line
modifi
respiratori
mucosa
connect
antrum
mastoid
occur
age
may
particularli
sever
older
adult
infect
mastoid
follow
middl
ear
infect
initi
hyperemia
edema
mucos
line
air
cell
serou
purul
exud
collect
cell
necrosi
bone
caus
pressur
purul
exud
thin
boni
septa
follow
coalesc
pu
contigu
area
result
abscess
caviti
bacteriolog
mastoid
aom
includ
pneumonia
h
influenza
major
pathogen
patient
persist
perfor
tympan
membran
may
invas
organ
ear
canal
includ
pseudomona
spp
pattern
similar
chang
pneumococc
isol
respons
aom
sinc
introduct
also
identifi
children
acut
mastoid
includ
emerg
multidrugresist
serotyp
acut
mastoid
usual
accompani
acut
infect
middl
ear
earli
stage
sign
aom
hear
loss
otalgia
fever
subsequ
swell
red
increas
number
episod
aom
caus
nonvaccin
organ
children
receiv
increas
nonvaccin
serotyp
pneumococc
aom
increas
episod
caus
h
influenza
data
suggest
vaccin
success
reduc
carriag
vaccin
serotyp
pneumococc
carriag
replenish
nonvaccin
serotyp
subsequ
spread
upper
respiratori
tract
middl
ear
caus
aom
exampl
serotyp
replac
emerg
multidrugresist
serotyp
strain
includ
increas
caus
invas
diseas
otiti
media
conjug
pneumococc
vaccin
prevnar
pfizer
vaccin
philadelphia
pa
introduc
replac
unit
state
addit
serotyp
addit
serotyp
includ
type
ad
data
may
assess
efficaci
prevent
aom
caus
addit
serotyp
vaccin
pneumococc
polysaccharid
conjug
carrier
protein
nontyp
h
influenza
develop
glaxosmithklin
glaxosmithklin
biolog
rixensart
belgium
clinic
trial
vaccin
efficaci
prevent
aom
conduct
czech
republ
slovakia
vaccin
prevent
aom
episod
caus
pneumococc
vaccin
serotyp
episod
caus
nontyp
h
influenza
vaccin
introduc
vaccin
combin
serotyp
synflorix
glaxosmithklin
biolog
vaccin
licens
europ
region
avail
unit
state
reason
effect
prevent
invas
pneumococc
diseas
prevent
vaccin
serotyp
pneumococc
aom
uncertain
suggest
higher
concentr
serum
antibodi
necessari
prevent
local
mucos
diseas
aom
import
respiratori
virus
pathogenesi
aom
viral
vaccin
could
prevent
valu
inactiv
parenter
influenza
viru
vaccin
document
decreas
incid
aom
children
daycar
finland
north
carolina
reduct
episod
febril
otiti
media
also
report
children
administr
liveattenu
intranas
influenza
vaccin
immunoprophylaxi
respiratori
syncyti
viru
diseas
progress
use
hightit
respiratori
syncyti
viru
rsv
immun
globulin
introduct
palivizumab
rsv
monoclon
antibodi
immun
globulin
high
titer
neutral
rsv
antibodi
rsv
immun
globulin
monoclon
antibodi
effect
reduc
number
episod
aom
surgic
manag
recurr
episod
aom
persist
effus
middl
ear
includ
use
myringotomi
adenoidectomi
placement
tympanostomi
tube
myringotomi
incis
tympan
membran
method
drain
middl
ear
fluid
introduct
antimicrobi
agent
myringotomi
primari
method
manag
suppur
otiti
media
today
use
myringotomi
limit
relief
intract
ear
pain
hasten
resolut
mastoid
infect
drainag
persist
middl
ear
effus
unrespons
medic
therapi
enlarg
adenoid
may
obstruct
orific
eustachian
tube
posterior
portion
nasopharynx
interfer
adequ
ventil
drainag
middl
ear
studi
use
adenoidectomi
children
prolong
effus
middl
ear
identifi
select
children
benefici
effect
reduc
time
spent
effus
tympanostomi
tube
resembl
small
collar
button
place
incis
tympan
membran
provid
drainag
fluid
ventil
middl
ear
placement
tube
one
common
surgic
procedur
children
criteria
placement
tube
includ
persist
middl
ear
effus
unrespons
adequ
medic
treatment
period
month
persist
neg
pressur
hear
improv
dramat
placement
ventil
tube
eustachian
tube
tegmen
canal
canal
must
clean
fresh
pu
obtain
exud
tympan
membran
tympan
membran
perfor
tympanocentesi
perform
obtain
materi
middl
ear
antimicrobi
drug
choic
acut
infect
similar
aomantibiot
activ
pneumonia
h
influenza
diseas
mastoid
prolong
cours
coverag
aureu
gramneg
enter
bacilli
may
consid
initi
therapi
result
cultur
becom
avail
mastoidectomi
perform
abscess
form
mastoid
bone
procedur
perform
antimicrobi
agent
control
sepsi
tender
present
mastoid
bone
pinna
displac
outward
downward
purul
discharg
may
emerg
perfor
tympan
membran
chronic
otiti
media
mastoid
erod
roof
antrum
caus
tempor
lobe
abscess
extend
posteriorli
caus
septic
thrombosi
later
sinu
radiograph
mastoid
area
may
show
loss
sharp
shadow
cellular
wall
caus
deminer
boni
septa
cloudi
area
pneumat
caus
inflammatori
swell
air
cell
comput
tomographi
help
delin
extent
diseas
cultur
bacteria
ear
drainag
fluid
must
taken
care
distinguish
fresh
drainag
fluid
materi
extern
